Literature DB >> 27125596

Mutation of rnf213a by TALEN causes abnormal angiogenesis and circulation defects in zebrafish.

Jun Wen1, Xunsha Sun1, Huimin Chen1, Huijiao Liu1, Rong Lai1, Jiaoxing Li1, Yufang Wang1, Jingjing Zhang2, Wenli Sheng3.   

Abstract

Moyamoya disease (MMD) is characterized by a stenosis at the terminal of the internal carotid artery and an abnormal vascular network at the base of the brain. RNF213 is a susceptibility gene for MMD in East Asians. The role of RNF213 in the etiology of MMD remains unknown. Here we generated rnf213a mutant zebrafish using transcription activator-like effector nuclease (TALEN) technique and described the characteristics of a zebrafish embryonic model of MMD. rnf213a mutant zebrafish developed abnormal angiogenesis in intersegmental vessels and cranial secondary vessels. Endothelial cells exhibited the defects in morphogenesis and formation of vascular tubes despite normal cell to cell contacts under electron microscope. Circulatory disorder was induced by abnormal sprouts in the trunk and head. Reduced circulation in the abnormal vessels was revealed by microangiography. No blood flow permeated across the vessels wall despite the extremely abnormal structure. rnf213a mutant showed lower erythrocyte velocity in dorsal aorta than that in wild-type siblings. In this study, we provided a promising in vivo model for MMD, and this model would aid to understand the function of rnf213a in angiogenesis.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Circulation; TALEN; Zebrafish; rnf213a

Mesh:

Substances:

Year:  2016        PMID: 27125596     DOI: 10.1016/j.brainres.2016.04.051

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Mutations of RNF213 are responsible for sporadic cerebral cavernous malformation and lead to a mulberry-like cluster in zebrafish.

Authors:  Jing Lin; Jie Liang; Jun Wen; Man Luo; Jiaoxing Li; Xunsha Sun; Xiaowei Xu; Jianli Li; Dongxian Wang; Jie Wang; Huimin Chen; Rong Lai; Fengyin Liang; Chuan Li; Fei Ye; Jingjing Zhang; Jinsheng Zeng; Shulan Yang; Wenli Sheng
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-04       Impact factor: 6.200

Review 2.  Experimental Animal Models for Moyamoya Disease: A Species-Oriented Scoping Review.

Authors:  Lei Cao; Yang Dong; Kaiwen Sun; Dongpeng Li; Hao Wang; Hongwei Li; Bo Yang
Journal:  Front Surg       Date:  2022-07-01

3.  Loss of mitochondrial ClpP, Lonp1, and Tfam triggers transcriptional induction of Rnf213, a susceptibility factor for moyamoya disease.

Authors:  Jana Key; Antonia Maletzko; Aneesha Kohli; Suzana Gispert; Sylvia Torres-Odio; Ilka Wittig; Juliana Heidler; Clea Bárcena; Carlos López-Otín; Yuanjiu Lei; A Phillip West; Christian Münch; Georg Auburger
Journal:  Neurogenetics       Date:  2020-04-28       Impact factor: 2.660

Review 4.  The Fra-1: Novel role in regulating extensive immune cell states and affecting inflammatory diseases.

Authors:  Yu-Yao He; Hai-Feng Zhou; Lu Chen; Yan-Ting Wang; Wan-Li Xie; Zhen-Zhen Xu; Yue Xiong; Yi-Qi Feng; Guo-Yang Liu; Xia Li; Jie Liu; Qing-Ping Wu
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

5.  A new syndrome of moyamoya disease, kidney dysplasia, aminotransferase elevation, and skin disease associated with de novo variants in RNF213.

Authors:  Alanna Strong; Gina O'Grady; Evelyn Shih; Jonathan R Bishop; Kathleen Loomes; Tamir Diamond; Erum A Hartung; William Wong; Sanmati Cuddapah; Anne Marie Cahill; Cuiping Hou; Diana Slater; Courtney Vaccaro; Deborah Watson; Dong Li; Hakon Hakonarson
Journal:  Am J Med Genet A       Date:  2021-05-07       Impact factor: 2.802

6.  FOSL1 is a novel mediator of endotoxin/lipopolysaccharide-induced pulmonary angiogenic signaling.

Authors:  Christopher R Nitkin; Sheng Xia; Heather Menden; Wei Yu; Min Xiong; Daniel P Heruth; Shui Qing Ye; Venkatesh Sampath
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.